ROCKVILLE, MD, May 11, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that Aprile Pilon, PhD, Chief Scientific Officer and Founder, will be presenting noteworthy new data regarding clinically relevant scientific findings related to the recombinant human Club Cell 10kDa Protein (rhCC10) drug platform.

For more information, read here.